08.13.13
WuXi PharmaTech
2Q Revenues: $142.3 million (+9%)
2Q Earnings: $29.6 million (+45%)
YTD Revenues: $274.2 million (+10%)
YTD Earnings: $51.3 million (+24%)
Comments: Laboratory Services revenue was up 13% to $105.9 million in the quarter. China-based Lab Services revenue was up 19% to $83.4 million. U.S.-based Lab Services revenue was down 3% to $22.5 million. Manufacturing Services revenue was $36.4 million, down 1%.
2Q Revenues: $142.3 million (+9%)
2Q Earnings: $29.6 million (+45%)
YTD Revenues: $274.2 million (+10%)
YTD Earnings: $51.3 million (+24%)
Comments: Laboratory Services revenue was up 13% to $105.9 million in the quarter. China-based Lab Services revenue was up 19% to $83.4 million. U.S.-based Lab Services revenue was down 3% to $22.5 million. Manufacturing Services revenue was $36.4 million, down 1%.